Skip to main content

ENvue Medical, Inc.

corporate_fare Company Profile

ENvue Medical, Inc.

NAOV·NASDAQ·Industrial Applications And Services·CIK 0001326706

ENvue Medical, Inc. was incorporated as a Delaware corporation in October 2003. The company changed its name from NanoVibronix, Inc. to ENvue Medical, Inc. in December 2025. This name change followed a merger completed on February 14, 2025. Following the merger, ENvue Medical, Inc. operates through two wholly-owned subsidiaries. The first is NanoVibronix Ltd. ("Nano OpCo"), a private company incorporated under the laws of the State of Israel. Nano OpCo focuses on non-invasive, biological response-activating medical devices. These devices are designed for home use without requiring medical professional assistance and target biofilm prevention and pain therapy. The second subsidiary is ENvue Medical Holdings LLC, a Delaware limited liability company. This entity is a medical device company involved in the research, development, production, marketing, and sale of medical devices specifically in the field of enteral feeding. ENvue Medical Holdings LLC is currently in the initial growth stage of commercialization.

ENvue Medical, Inc. (NASDAQ:NAOV) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for NAOV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-14, rated 8/10. Recent SEC coverage for NAOV spans 8-K.

Recent high-impact activity:

  • ENvue Medical Secures $1M Secured Note and Cuts Series X Conversion Price to $0.50

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.55M
Net Income
-$18.18M
Diluted EPS
-$26.69
Op. Cash Flow
-$9.37M
Free Cash Flow
-$9.43M
Gross Profit
$153K
Operating Income
-$22.89M
Cash & Equivalents
$4.22M
Debt / Equity
0.00×
Net Margin
-7.12×
Shares Outstanding
1.1M sh
Source: 10-K · filed 2026-04-15 · accession 0001493152-26-016871
$4.02
Market cap
$4.37M
Volume
32.9K (1.1× avg)
3-mo avg 28.9K
Last traded · 2025-12-12

show_chartPrice Chart

Loading chart...

feed NAOV - Latest Insights

NAOV
Oct 14, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.02
Real-time Price: $4.02 info
Change: $0 (0%) info
Market Cap: $4.375M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets